Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Luisa, Foltran"'
Autor:
Roberto Innocente, Federico Navarria, Roberto Petri, Elisa Palazzari, Massimo Vecchiato, Jerry Polesel, Antonio Ziccarelli, Antonio Martino, Paolo Ubiali, Dino Tonin, Andrea Lauretta, Claudio Belluco, Luisa Foltran, Angela Buonadonna, Arben Lleshi, Carlotta Benedetta Colombo, Loredana Barresi, Marco Gigante, Giovanni Franchin, Antonino De Paoli
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeTo explore the feasibility and efficacy of a dose intensification with Intensity Modulated Radiation Therapy and Simultaneous Integrated Boost (IMRT-SIB) in locally advanced esophageal and gastroesophageal cancer (GEJ).Methods and MaterialsWe
Externí odkaz:
https://doaj.org/article/52e2821f059f4285a11a0febc6c4ea48
Autor:
Martina Zanchetta, Valentina Iacuzzi, Bianca Posocco, Giorgia Bortolin, Ariana Soledad Poetto, Marco Orleni, Giovanni Canil, Michela Guardascione, Luisa Foltran, Valentina Fanotto, Fabio Puglisi, Sara Gagno, Giuseppe Toffoli
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Lenvatinib (LENVA) is an oral antineoplastic drug used for the treatment of hepatocellular carcinoma and thyroid carcinoma. LENVA therapeutic drug monitoring (TDM) should be mandatory for a precision medicine to optimize the drug dosage. To this end,
Externí odkaz:
https://doaj.org/article/f9a48936ad72401cbcdf79e1c04c6527
Autor:
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi
Publikováno v:
Cells, Vol 10, Iss 8, p 2034 (2021)
Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the second leading cause of cancer-related mortality. HCC typically arises within a cirrhotic liver, but in about 20% of cases occurs in absence of cirrhosis. Among non-ci
Externí odkaz:
https://doaj.org/article/9827d7de86b3467e845011b919ce5e01
Autor:
Marco de Scordilli, Anna Michelotti, Diego Zara, Lorenza Palmero, Martina Alberti, Claudia Noto, Fabiana Totaro, Luisa Foltran, Michela Guardascione, Donatella Iacono, Elena Ongaro, Gianpiero Fasola, Fabio Puglisi
Publikováno v:
Critical Reviews in Oncology/Hematology. 186:104013
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b2c6178b26cb6ed80bfc31499acff99
https://doi.org/10.1016/j.critrevonc.2023.104013
https://doi.org/10.1016/j.critrevonc.2023.104013
Autor:
Elena Ongaro, Debora Basile, Lorenzo Gerratana, Fabio Puglisi, Massimo Di Maio, Silvio Ken Garattini, Valentina Fanotto, F. Cortiula, Marcella Montico, Giacomo Pelizzari, C. Lisanti, Marco Audisio, Giovanni Gerardo Cardellino, Donatella Iacono, Gianpiero Fasola, Nicoletta Pella, Giuseppe Aprile, Angela Buonadonna, C. Corvaja, Luisa Foltran
Publikováno v:
Oncologist
Background Monocyte-to-lymphocyte ratio (MLR) and lactate dehydrogenase (LDH) levels are circulating biomarkers that provide information about tumor-related inflammation and immune suppression. This study aimed to evaluate the prognostic role of MLR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4379781846d0bb57bdd94b8c1c9ac675
https://doi.org/10.1634/theoncologist.2019-0780
https://doi.org/10.1634/theoncologist.2019-0780
Autor:
Camilla Lisanti, Debora Basile, Silvio Ken Garattini, Annamaria Parnofiello, Carla Corvaja, Francesco Cortiula, Elisa Bertoli, Elena Ongaro, Luisa Foltran, Mariaelena Casagrande, Paola Di Nardo, Giovanni Gerardo Cardellino, Gianpiero Fasola, Angela Buonadonna, Nicoletta Pella, Giuseppe Aprile, Fabio Puglisi
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 175
Background: Emerging data suggest that gender-related immune system composition affects both immune response and efficacy of immunotherapy in cancer patients (pts). This study aimed to investigate the sex-related prognostic role of MLR in metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5212e317d8daabbb651977041f17095d
https://doi.org/10.3390/cancers15010175
https://doi.org/10.3390/cancers15010175
Autor:
Michela Guardascione, Rossana Roncato, L. Palmero, A. Michelotti, Elena Ongaro, Luisa Foltran, Fabio Puglisi, Marco de Scordilli, Mario Masala
Publikováno v:
Cells, Vol 10, Iss 2034, p 2034 (2021)
Cells
Cells
Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the second leading cause of cancer-related mortality. HCC typically arises within a cirrhotic liver, but in about 20% of cases occurs in absence of cirrhosis. Among non-ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef80ecf79e22c93c024d80862490ff48
https://www.mdpi.com/2073-4409/10/8/2034
https://www.mdpi.com/2073-4409/10/8/2034
Autor:
Francesco Angelini, Michela Guardascione, Erika Cecchin, Luisa Foltran, Giuseppe Toffoli, Tania Di Raimo, Mario D'Andrea, Elena De Mattia
Publikováno v:
World Journal of Gastroenterology
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. To date, most patients with HCC are diagnosed at an advanced tumor stage, excluding them from potentially curative therapies (i.e., resection, liver transplantation, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6b47e21cefff6be0ae7fa81c901f2f
https://doi.org/10.3748/wjg.v25.i29.3870
https://doi.org/10.3748/wjg.v25.i29.3870
Autor:
Alberto Sobrero, Nicoletta Pella, Mauro Magnani, Maria Teresa Ionta, Pietro Sozzi, Vittorina Zagonel, Luisa Foltran, Francesco Graziano, Roberto Labianca, Silvia Lazzarelli, Monica Ronzoni, Enzo Veltri, Annamaria Ruzzo, Francesca Bergamo, Daniele Turci, Eliana Rulli, Luciano Frontini, Claudio Verusio, Sandro Barni, Claudia Mucciarini, Edoardo Biondi, Vincenzo Ricci, M. Nicolini, Annalisa Bramati, Sara Lonardi, Bruno Massidda, Francesca Galli, F. Galli, Irene Bagaloni
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports
Polymorphisms contribute to inter-individual differences and show a promising predictive role for chemotherapy-related toxicity in colon cancer (CC). TOSCA is a multicentre, randomized, non-inferiority, phase III study conducted in high-risk stage II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea02efe822c3d2a15edac37f32eb0dd5
http://link.springer.com/article/10.1038/s41598-019-47627-1
http://link.springer.com/article/10.1038/s41598-019-47627-1
Autor:
Antonio Martino, E. Palazzari, Jerry Polesel, Claudio Belluco, Giovanni Franchin, Luisa Foltran, Roberto Innocente, Massimo Vecchiato, Paolo Ubiali, Carlotta Benedetta Colombo, Roberto Petri, Antonino De Paoli, Antonio Ziccarelli, Arben Lleshi, Angela Buonadonna, F. Navarria, Loredana Barresi, A. Lauretta, Dino Tonin, M. Gigante
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
PurposeTo explore the feasibility and efficacy of a dose intensification with Intensity Modulated Radiation Therapy and Simultaneous Integrated Boost (IMRT-SIB) in locally advanced esophageal and gastroesophageal cancer (GEJ).Methods and MaterialsWe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abb16b8e38c38b9ab976174ee345981